DICK'S Sporting Goods, Inc. (DKS)

CTI BioPharma Income Statement

Financials in millions USD. Fiscal year is March - February.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 3, 2025	Feb 1, 2025	Feb 3, 2024	Jan 28, 2023	Jan 29, 2022	Jan 30, 2021
Revenue	13,599	13,443	12,984	12,368	12,293	9,584
Revenue Growth (YoY)	3.33%	3.53%	4.98%	0.61%	28.27%	9.52%
Cost of Revenue	8,704	8,617	8,439	8,084	7,581	6,533
Gross Profit	4,895	4,826	4,546	4,285	4,712	3,051
Selling, General & Admin	3,336	3,294	3,111	2,800	2,664	2,299
Operating Expenses	3,386	3,352	3,179	2,822	2,677	2,309
Operating Income	1,509	1,474	1,367	1,463	2,035	741.48
Interest Expense	-60.49	-52.99	-58.02	-95.22	-57.84	-48.81
Other Non Operating Income (Expenses)	89.54	98.09	93.81	15.95	17.77	19.07
EBT Excluding Unusual Items	1,538	1,519	1,403	1,384	1,994	711.74
Merger & Restructuring Charges	-	-	-84.8	-	-	-
Pretax Income	1,524	1,519	1,318	1,384	1,994	711.74
Income Tax Expense	370.1	353.73	271.63	340.61	474.57	181.48
Net Income	1,154	1,165	1,047	1,043	1,520	530.25
Net Income to Common	1,154	1,165	1,047	1,043	1,520	530.25
Net Income Growth	13.48%	11.35%	0.32%	-31.37%	186.63%	78.26%
Shares Outstanding (Basic)	80	80	82	78	83	84
Shares Outstanding (Diluted)	82	83	86	99	110	93
Shares Change (YoY)	-2.23%	-3.49%	-13.45%	-9.40%	18.29%	4.01%
EPS (Basic)	14.40	14.48	12.72	13.43	18.27	6.29
EPS (Diluted)	14.00	14.05	12.18	10.78	13.87	5.72
EPS Growth	16.10%	15.34%	13.02%	-22.28%	142.49%	71.26%
Free Cash Flow	348.4	509.27	939.91	557.81	1,309	1,329
Free Cash Flow Per Share	4.22	6.14	10.94	5.62	11.94	14.34
Dividend Per Share	4.513	4.400	4.000	1.950	1.600	1.250
Dividend Growth	10.06%	10.00%	105.13%	21.88%	28.00%	13.64%
Gross Margin	36.00%	35.90%	35.01%	34.64%	38.33%	31.83%
Operating Margin	11.10%	10.96%	10.53%	11.83%	16.55%	7.74%
Profit Margin	8.49%	8.67%	8.06%	8.43%	12.36%	5.53%
Free Cash Flow Margin	2.56%	3.79%	7.24%	4.51%	10.64%	13.86%
EBITDA	1,916	1,874	1,726	1,800	2,357	1,063
EBITDA Margin	14.09%	13.94%	13.29%	14.55%	19.17%	11.09%
D&A For EBITDA	406.79	400.41	358.43	336.98	322.55	321.8
EBIT	1,509	1,474	1,367	1,463	2,035	741.48
EBIT Margin	11.10%	10.96%	10.53%	11.83%	16.55%	7.74%
Effective Tax Rate	24.28%	23.29%	20.61%	24.62%	23.79%	25.50%
Advertising Expenses	-	519	478.1	412.2	410.9	293.4

Updated May 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q